| |
|
|
|
Citius Pharmaceuticals- Inc.  
|
|
2.74 0.11 (0.04%) |
07-20 15:55 |
|
Open: |
0 |
Pre close: |
2.63 |
Target:
|
3.68
|
|
High: |
2.8 |
Low: |
2.59 |
Resistance:
|
3.15
3.68
|
|
Volume: |
31,291 |
Market Cap: |
29M |
Support:
|
2.49
2.08
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.66
 |
MACD |
MACD(12,26):
|
0.05  |
|
MA(20): |
2.50 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
2.76 |
Stochastic Oscillator |
%K(14,3):
|
54.35 |
|
MA(250): |
3.39 |
%D(3): |
52.80 |
|
Average Volume(K) |
3-Month: |
4313
|
52-Week |
High:
|
5.79 |
|
10-Days: |
16333 |
Low: |
2.08 |
|
RSI |
RSI(14):
|
55.51 |
Change(%): |
-52.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-70.1 |
Shares Out. (M) |
10.68 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-55.4 |
Shares Float (M) |
6.38 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
40.30 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.70 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2 |
|
Book Value (p.s.) |
1.330 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.06 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.40 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-10.11 |
P/CF |
-2.36 |
|
|
|
|
|
|
